Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,185 | 23 | 88.3% |
| Education | $157.00 | 5 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $461.53 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $292.26 | 6 | $0 (2023) |
| Astellas Pharma US Inc | $124.55 | 1 | $0 (2017) |
| AKEBIA THERAPEUTICS INC | $122.91 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $67.04 | 2 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $57.38 | 2 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $56.48 | 3 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $54.09 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46.80 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $29.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.44 | 11 | Novartis Pharmaceuticals Corporation ($67.04) |
| 2023 | $61.71 | 3 | Calliditas Therapeutics US Inc. ($34.71) |
| 2022 | $36.20 | 2 | Otsuka America Pharmaceutical, Inc. ($23.46) |
| 2020 | $143.40 | 4 | Otsuka America Pharmaceutical, Inc. ($118.60) |
| 2019 | $423.16 | 4 | Fresenius USA Marketing, Inc. ($300.25) |
| 2018 | $246.19 | 3 | Otsuka America Pharmaceutical, Inc. ($123.20) |
| 2017 | $124.55 | 1 | Astellas Pharma US Inc ($124.55) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.15 | General |
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Nephrology | ||||||
| 09/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/30/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: DIABETES | ||||||
| 06/25/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/27/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: NEPHROLOGY | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: DIABETES | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.89 | General |
| 11/28/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 11/21/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEPHROLOGY | ||||||
| 09/12/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Nephrology | ||||||
| 09/15/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/08/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: NEPHROLOGY | ||||||
| 09/21/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $24.80 | General |
| Category: NEPHROLOGY | ||||||
| 09/17/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $18.80 | General |
| Category: NEPHROLOGY | ||||||
| 09/17/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $4.29 | General |
| Category: NEPHROLOGY | ||||||
| 08/31/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $95.51 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $55.80 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/17/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $123.38 | General |
| 03/07/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: NEPHROLOGY | ||||||
| 01/10/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $121.07 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/05/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $123.20 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 407 | 911 | $592,306 | $120,456 |
| 2022 | 3 | 67 | 260 | $243,274 | $47,505 |
| 2021 | 3 | 44 | 163 | $192,736 | $41,583 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 110 | 456 | $207,024 | $46,521 | 22.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 22 | 118 | $183,962 | $35,583 | 19.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 16 | 44 | $56,892 | $11,165 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 109 | 129 | $55,470 | $10,766 | 19.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 79 | 86 | $51,342 | $9,580 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $20,848 | $3,653 | 17.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 19 | 24 | $10,344 | $2,000 | 19.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 20 | 22 | $6,424 | $1,189 | 18.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 15 | 86 | $134,074 | $26,330 | 19.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 138 | $62,652 | $11,982 | 19.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 16 | 36 | $46,548 | $9,193 | 19.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 18 | 95 | $136,783 | $29,783 | 21.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 35 | $40,971 | $8,854 | 21.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 33 | $14,982 | $2,947 | 19.7% |
About Dr. John Sy, M.D
Dr. John Sy, M.D is a Nephrology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1639435738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sy, M.D has received a total of $1,342 in payments from pharmaceutical and medical device companies, with $306.44 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,185).
As a Medicare-enrolled provider, Sy has provided services to 518 Medicare beneficiaries, totaling 1,334 services with total Medicare billing of $209,545. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Long Beach, CA
- Active Since 04/03/2012
- Last Updated 06/21/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1639435738
Products in Payments
- JYNARQUE (Drug) $346.35
- Velphoro (Drug) $335.21
- Astagraf XL (Drug) $124.55
- AURYXIA (Drug) $122.91
- LUPKYNIS (Drug) $57.38
- TARPEYO (Drug) $56.48
- JARDIANCE (Drug) $46.80
- LOKELMA (Drug) $29.70
- Kerendia (Drug) $28.91
- Cyclers (Device) $2.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Long Beach
Ngoc-Tram Tran, D.o, D.O
Nephrology — Payments: $8,583
Sapna Patel, Md, MD
Nephrology — Payments: $6,282
Dr. John Hsieh, M.d, M.D
Nephrology — Payments: $4,881
Thuc Tu, Md, MD
Nephrology — Payments: $4,311
Arvind Mehta, Md, MD
Nephrology — Payments: $1,700
Essam Maasarani, M.d, M.D
Nephrology — Payments: $1,662